The National Institutes of Health, through its NIH Guide, has recently published the following funding-related notices and funding opportunities:

Policy Notices

Updated Reporting Requirements for RADx-rad Grant Recipients
National Institutes of Health
 

Continued Extension of Certain Flexibilities for Prospective Basic Experimental Studies With Human Participants
National Institutes of Health
 

General Notices

Notice of Information: NIAAA Clinical Medications Development Testing Program
National Institute on Alcohol Abuse and Alcoholism
 

Notice of Pre-Application Information Webinar for PAR-21-092, "NIDA Translational Avant-Garde Award for Development of Medication to Treat Substance Use Disorders (UG3/UH3 Clinical Trial Optional)"
National Institute on Drug Abuse

Updated NHLBI Guidance Concerning Mentored Career Development (K08 and K23) Awards: Percent Effort
National Heart, Lung, and Blood Institute
 

Updated Notice of Limited Availability of Research Non-Human Primates
Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
 

Expansion of Eligibility: Technical and Business Assistance (TABA) Needs Assessment Program for National Institutes of Health (NIH) Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Awardees
National Institutes of Health
 

Request for Information: Challenges and Opportunities in Understanding Cellular Senescence and Senolytics
Office of Strategic Coordination (Common Fund)
 

Notice of Changes to Funding Opportunities

Notice of Clarification of Research Priorities for RFA-AA-21-002 "SARS-CoV-2, COVID-19 and Consequences of Alcohol Use (R01 Clinical Trial Not Allowed) "
National Institute on Alcohol Abuse and Alcoholism
 

Notice of Clarification of Research Priorities for RFA-AA-21-003 "SARS-CoV-2, COVID-19 and Consequences of Alcohol Use (R03 Clinical Trial Not Allowed) "
National Institute on Alcohol Abuse and Alcoholism
 

Notice of Clarification of Research Priorities for RFA-AA-21-004 "SARS-CoV-2, COVID-19 and Consequences of Alcohol Use (R21 Clinical Trial Not Allowed)"
National Institute on Alcohol Abuse and Alcoholism
 

Notice of Early Expiration of PAR-19-346 "Investigations on Primary Immunodeficiency Diseases/Inborn Errors of Immunity (R21 Clinical Trial Not Allowed)"
National Institute of Allergy and Infectious Diseases
 

Notice of Early Expiration of PAR-19-347 "Investigations on Primary Immunodeficiency Diseases/Inborn Errors of Immunity (R03 Clinical Trial Not Allowed)"
National Institute of Allergy and Infectious Diseases
 

Notice of Early Expiration of PA-19-068, Secondary Analysis of Existing Datasets for Advancing Infectious Disease Research (R21 Clinical Trial Not Allowed)
National Institute of Allergy and Infectious Diseases
 

Notice of Change to Eligibility Information in RFA-AI-20-080, "Human Immunology Project Consortium (HIPC) Coordinating Center (U01 Clinical Trial Not Allowed)"
National Institute of Allergy and Infectious Diseases
 

Notice of Extension of Application Due Date for RFA-DK-20-034, "Program to Advance the Career Development of Scientists from Diverse Backgrounds Conducting Nutrition, Obesity, Diabetes, and Related Research (U24 Clinical Trial Optional)"
National Institute of Diabetes and Digestive and Kidney Diseases
 

Notice of Change to the Application Due Date(s) for PAR-20-083 titled "Enhancing Regulatory Science for Advancing Pharmaceutical Quality and Manufacturing (U01) Clinical Trials Optional.
Food and Drug Administration
 

Notice of NICHD Participation in PAR-20-266, "Promoting Research on Music and Health: Phased Innovation Award for Music Interventions (R61/R33 Clinical Trial Optional)"
Eunice Kennedy Shriver National Institute of Child Health and Human Development
 

Notice of NICHD Participation in PAR-21-099, "Music and Health: Understanding And Developing Music Medicine (R21 Clinical Trial Optional)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
 

Notice of NICHD Participation in PAR-21-100, "Music and Health: Understanding And Developing Music Medicine (R01 Clinical Trial Optional)"
Eunice Kennedy Shriver National Institute of Child Health and Human Development
 

Notice of Change to AIDS Date of RFA-MH-21-120, "Mental Health Research Awards for Investigators Early in their Career in Low and Middle-Income Countries (R01 Clinical Trial Optional)"
National Institute of Mental Health
 

Notice of Change to Key Dates for RFA-NS-20-006 "BRAIN Initiative: Biology and Biophysics of Neural Stimulation and Recording Technologies (R01 Clinical Trials Optional)"
National Institute of Neurological Disorders and Stroke
National Center for Complementary and Integrative Health
 

Notice of Corrections to PAR-20-181, Limited Competition: National Primate Research Centers (P51) (Clinical Trials Not Allowed)
Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
 

Notice of Change: Change in Data Table Submission Requirements for PAR-21-120, Global Infectious Disease Research Training Program (D43 Clinical Trial Optional)
John E. Fogarty International Center
 

Notices of Intent to Publish

Notice of Intent to Publish Funding Opportunity Announcements for the RADx-UP Initiative (Phase II)
National Institutes of Health
Office of Research on Women's Health
 

Notice of Intent to Publish a Funding Opportunity Announcement for PHS 2021 Omnibus Solicitations of the NIH, CDC, and FDA for Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Grant Applications
National Institutes of Health
 

Notices of Special Interest

Notice of Special Interest (NOSI): Investigations on Inborn Errors of Immunity/Primary Immunodeficiencies
National Institute of Allergy and Infectious Diseases
 

Notice of Special Interest (NOSI): Administrative Supplement for Genome-wide Genotyping of Existing Samples from Minority Racial/Ethnic Populations and Sharing of Associated Epidemiologic Data
National Cancer Institute
 

Notice of Special Interest (NOSI): Synthetic Psychoactive Drugs and Strategic Approaches to Counteract Their Deleterious Effects
National Institute on Drug Abuse
 

Notice of Special Interest (NOSI): Administrative Supplements for research on fentanyl and derivatives
National Institute on Drug Abuse
 

Notice of Special Interest (NOSI): Basic Research on Fentanyl and Synthetic Fentanyl Analogs: Signaling, Neurobiology, and Pharmacology
National Institute on Drug Abuse
 

Notice of Special Interest (NOSI): Stimulate Research on the Diagnosis, Treatment, and Mechanistic Understanding of Postural Orthostatic Tachycardia Syndrome (POTS)
National Heart, Lung, and Blood Institute
National Institute of Neurological Disorders and Stroke
 

Notice of Special Interest (NOSI): Characterization of Genomics of Induced Pluripotent Stem Cell Lines for AD/ADRD Research
National Institute of Neurological Disorders and Stroke
 

Notice of Special Interest (NOSI): Administrative Supplement for Providing Technical and Business Assistance (TABA) Funding to SBIR/STTR Awardees (Admin Supp)
National Institutes of Health
National Center for Advancing Translational Sciences
National Center for Complementary and Integrative Health
National Eye Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Institute of Allergy and Infectious Diseases
National Institute of Biomedical Imaging and Bioengineering
National Institute on Deafness and Other Communication Disorders
National Institute of Dental and Craniofacial Research
National Institute of General Medical Sciences
National Institute of Mental Health
National Institute of Nursing Research
Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
 

Notice of Special Interest (NOSI): Administrative Supplements for COVID-19-Impacted FIC Research Training and Education Awards
John E. Fogarty International Center
 

Notice of Special Interest (NOSI): Administrative Supplements to FIC Awards for COVID-19-related Research in Low- or Middle-Income Countries
John E. Fogarty International Center
 

Funding Opportunities

NHGRI Predoctoral to Postdoctoral Transition Award for a Diverse Genomics Workforce (F99/K00)
National Human Genome Research Institute

Developing Digital Therapeutics for Substance Use Disorders (UG3/UH3 Clinical Trial optional)
National Institute on Drug Abuse
 

Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Not Allowed)
National Cancer Institute
National Institute of Dental and Craniofacial Research
 

Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Optional)
National Cancer Institute
 

Cutting-Edge Basic Research Awards (CEBRA) (R21 Clinical Trial Optional)
National Institute on Drug Abuse
 

Limited Competition: Alzheimers Disease Sequencing Project Follow-Up Study 2.0 (ADSP FUS 2.0): The Diverse Population Initiative (U01 Clinical Trial Not Allowed)
National Institute on Aging
 

Short Courses on Interdisciplinary Behavioral and Social Sciences Research on Aging (R25 - Clinical Trial Not Allowed)
Short Courses on Interdisciplinary Behavioral and Social Sciences Research on Alzheimer's Disease and Related Dementias (R25 - Clinical Trial Not Allowed)    
National Institute on Aging
 

Neural Mechanisms of Force-Based Manipulations: High Priority Research Networks (U24 Clinical Trial Optional)
National Center for Complementary and Integrative Health
National Institute of Neurological Disorders and Stroke
 

SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer-Relevant Technologies Toward Commercialization (R44 Clinical Trial Optional)
National Cancer Institute
 

Strategies that Support Global Food Safety (U01) Clinical Trial Not Allowed
Food and Drug Administration
 

AAV Vector manufacturing for diseases affecting very small populations (R01) Clinical Trials Not Allowed
Food and Drug Administratio Center for Biologics Evaluation and Research n
 

Recompetition of the Pediatric Scientist Development Program (PSDP) (K12 Clinical Trial Not Allowed)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
 

Understanding and Addressing the Impact of Structural Racism and Discrimination on Minority Health and Health Disparities (R01 Clinical Trial Optional)
National Institute on Minority Health and Health Disparities
National Center for Complementary and Integrative Health
National Cancer Institute
National Eye Institute
National Human Genome Research Institute
National Heart, Lung, and Blood Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Institute of Allergy and Infectious Diseases
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute of Biomedical Imaging and Bioengineering
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
National Institute of Dental and Craniofacial Research
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Environmental Health Sciences
National Institute of General Medical Sciences
National Institute of Mental Health
National Institute of Neurological Disorders and Stroke
National Institute of Nursing Research
Office of Behavioral and Social Sciences Research
Office of the Director, NIH
Office of Disease Prevention
Office of Research on Women's Health
 

Transformative Research to Address Health Disparities and Advance Health Equity (U01 Clinical Trial Allowed)
 Transformative Research to Address Health Disparities and Advance Health Equity at Minority Serving Institutions (U01 Clinical Trial Allowed)     
Office of Strategic Coordination (Common Fund)

 

Members of the University of Iowa community may direct questions to the UI Division of Sponsored Programs at dsp@uiowa.edu or 335-2123, or email Carrie Damon at carolyn-damon@uiowa.edu or Dave Myers at dave-myers@uiowa.edu or Lynn Hudachek at lynn-hudachek @uiowa.edu.